Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3527
+0.0204 (6.14%)
At close: Jun 27, 2025, 4:00 PM
0.3500
-0.0027 (-0.77%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.16 million as of June 27, 2025. Its market cap has decreased by -87.79% in one year.
Market Cap
8.16M
Enterprise Value
-13.00M
1-Year Change
-87.79%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.16M, a decrease of -96.81%. That is a compound annual growth rate of -83.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 8.16M | -28.98% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |